Therefore, the intrahepatic level of aromatase may be reasonably postulated to be influenced by that of the factors above, which is different among several types of inflammatory or neoplastic disease such as hepatitis, cirrhosis, steatosis, HCC, and MLC [35]. The gene discussed is CYP19A1; the disease is hepatocellular carcinoma.